In vitro synergy studies with Clostridium difficile
- PMID: 2039211
- PMCID: PMC245055
- DOI: 10.1128/AAC.35.3.582
In vitro synergy studies with Clostridium difficile
Abstract
Agar dilution anaerobic susceptibility studies using rifampin, vancomycin, metronidazole, and bacitracin individually and in combination were performed with Clostridium difficile. Fifty-five strains of C. difficile were studied. Eighty-five percent of strains tested (29 of 34) were synergistically inhibited by the combination of bacitracin and rifampin (fractional inhibitory concentration, less than or equal to 0.50).
Similar articles
-
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.Antimicrob Agents Chemother. 2013 Jun;57(6):2882-6. doi: 10.1128/AAC.00261-13. Epub 2013 Apr 9. Antimicrob Agents Chemother. 2013. PMID: 23571539 Free PMC article.
-
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.Antimicrob Agents Chemother. 2002 Jun;46(6):1647-50. doi: 10.1128/AAC.46.6.1647-1650.2002. Antimicrob Agents Chemother. 2002. PMID: 12019070 Free PMC article.
-
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.Antimicrob Agents Chemother. 2006 May;50(5):1890-2. doi: 10.1128/AAC.50.5.1890-1892.2006. Antimicrob Agents Chemother. 2006. PMID: 16641471 Free PMC article.
-
Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.Antimicrob Agents Chemother. 1999 Nov;43(11):2607-11. doi: 10.1128/AAC.43.11.2607. Antimicrob Agents Chemother. 1999. PMID: 10543736 Free PMC article.
-
In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options.Clin Infect Dis. 1998 May;26(5):1169-76. doi: 10.1086/520309. Clin Infect Dis. 1998. PMID: 9597247 Review.
Cited by
-
Clostridium difficile infection: a common clinical problem for the general internist.J Gen Intern Med. 1994 Sep;9(9):528-33. doi: 10.1007/BF02599229. J Gen Intern Med. 1994. PMID: 7996299 Review.
-
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.Antimicrob Agents Chemother. 2013 Jun;57(6):2882-6. doi: 10.1128/AAC.00261-13. Epub 2013 Apr 9. Antimicrob Agents Chemother. 2013. PMID: 23571539 Free PMC article.
-
Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.Antimicrob Agents Chemother. 2006 Sep;50(9):3028-32. doi: 10.1128/AAC.00019-06. Antimicrob Agents Chemother. 2006. PMID: 16940098 Free PMC article. Clinical Trial.
-
Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective.Front Microbiol. 2017 Jun 29;8:1205. doi: 10.3389/fmicb.2017.01205. eCollection 2017. Front Microbiol. 2017. PMID: 28706513 Free PMC article. Review.
-
The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells.Gut Pathog. 2016 Jun 2;8:20. doi: 10.1186/s13099-016-0102-8. eCollection 2016. Gut Pathog. 2016. PMID: 27257437 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases